These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24169327)

  • 1. [Effects of genetic variations of cholesteryl ester transfer protein on atorvastatin treatment efficacy and clinical outcomes in patients with coronary artery disease].
    Gao J; Cong HL; Mao YM; Liu Y; Zhang N; Chen Q; Liu T; Cui RZ
    Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(28):2195-9. PubMed ID: 24169327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Influence of CETP gene -629C/A polymorphism on the efficacy of atorvastatin treatment and clinical outcome].
    Gao J; Cong HL; Mao YM; Liu Y; Zhang N; Chen Q; Liu T; Cui R
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Oct; 30(5):553-8. PubMed ID: 24078569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of CETP polymorphism on atorvastatin lipid-regulating effect and clinical prognosis of patients with coronary heart disease.
    Gu GL; Xu XL; Yang QY; Zeng RL
    Med Sci Monit; 2014 Dec; 20():2824-9. PubMed ID: 25547030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between cholesteryl ester transfer protein gene -629C→A mutations with HDL-C levels and coronary heart disease].
    Gao J; Mao YM; Cong HL; Liu Y; Zhang N; Chen Q; Liu T; Cui RZ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 May; 41(5):399-405. PubMed ID: 24021123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between the cholesterol ester transfer protein TaqIB polymorphism and the lipid-lowering effect of atorvastatin in patients with coronary atherosclerotic heart disease.
    Li J; Zhang L; Xie NZ; Deng B; Lv LX; Zheng LQ
    Genet Mol Res; 2014 Mar; 13(1):2140-8. PubMed ID: 24737438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common genetic variation of the cholesteryl ester transfer protein gene strongly predicts future cardiovascular death in patients with coronary artery disease.
    Blankenberg S; Rupprecht HJ; Bickel C; Jiang XC; Poirier O; Lackner KJ; Meyer J; Cambien F; Tiret L;
    J Am Coll Cardiol; 2003 Jun; 41(11):1983-9. PubMed ID: 12798569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common variants of HMGCR, CETP, APOAI, ABCB1, CYP3A4, and CYP7A1 genes as predictors of lipid-lowering response to atorvastatin therapy.
    Poduri A; Khullar M; Bahl A; Sehrawat BS; Sharma Y; Talwar KK
    DNA Cell Biol; 2010 Oct; 29(10):629-37. PubMed ID: 20578904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of cholesteryl ester transfer protein mass with peripheral leukocyte count following statin therapy: a pilot study.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2012 Oct; 12(5):349-54. PubMed ID: 22900989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common cholesteryl ester transfer protein gene polymorphisms and the effect of atorvastatin therapy in type 2 diabetes.
    van Venrooij FV; Stolk RP; Banga JD; Sijmonsma TP; van Tol A; Erkelens DW; Dallinga-Thie GM;
    Diabetes Care; 2003 Apr; 26(4):1216-23. PubMed ID: 12663600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease.
    Carlquist JF; Muhlestein JB; Horne BD; Hart NI; Bair TL; Molhuizen HO; Anderson JL
    Am Heart J; 2003 Dec; 146(6):1007-14. PubMed ID: 14660992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of cholesteryl ester transfer protein -629C > A polymorphism with high-density lipoprotein cholesterol levels in coronary artery disease patients.
    Tanrikulu S; Ademoglu E; Gurdol F; Mutlu-Turkoglu U; Bilge AK; Nisanci Y
    Cell Biochem Funct; 2009 Oct; 27(7):452-7. PubMed ID: 19784962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On-statin cholesteryl ester transfer protein mass and risk of recurrent coronary events (from the pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 [PROVE IT-TIMI 22] study).
    Khera AV; Wolfe ML; Cannon CP; Qin J; Rader DJ
    Am J Cardiol; 2010 Aug; 106(4):451-6. PubMed ID: 20691300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDL cholesterol response to GH replacement is associated with common cholesteryl ester transfer protein gene variation (-629C>A) and modified by glucocorticoid treatment.
    Dullaart RP; van den Berg G; van der Knaap AM; Dijck-Brouwer J; Dallinga-Thie GM; Zelissen PM; Sluiter WJ; van Beek AP
    Eur J Endocrinol; 2010 Feb; 162(2):227-34. PubMed ID: 19926784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesteryl ester transfer protein rs1532624 gene polymorphism is associated with reduced response to statin therapy.
    Yehya A; Irshaid Y; Saleh AA
    Curr Mol Pharmacol; 2013 Nov; 6(3):156-62. PubMed ID: 24160573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. I405V and -629C/A polymorphisms of the cholesteryl ester transfer protein gene in patients with coronary artery disease.
    Ghatreh Samani K; Noori M; Rohbani Nobar M; Hashemzadeh Chaleshtori M; Farrokhi E; Darabi Amin M
    Iran Biomed J; 2009 Apr; 13(2):103-8. PubMed ID: 19471550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesteryl ester transfer protein and ATP-binding cassette transporter A1 genotype alter the atorvastatin and simvastatin efficacy: time for genotype-guided therapy?
    Kolovou G; Kolovou V; Mihas C; Giannakopoulou V; Vasiliadis I; Boussoula E; Kollia A; Boutsikou M; Katsiki N; Mavrogeni S
    Angiology; 2013 May; 64(4):266-72. PubMed ID: 22584245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between CYP7A1 A-204C and ABCG8 C1199A polymorphisms on lipid lowering with atorvastatin.
    Wei KK; Zhang LR; Zhang Y; Hu XJ
    J Clin Pharm Ther; 2011 Dec; 36(6):725-33. PubMed ID: 21128988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: a population-based study.
    Borggreve SE; Hillege HL; Wolffenbuttel BH; de Jong PE; Zuurman MW; van der Steege G; van Tol A; Dullaart RP;
    J Clin Endocrinol Metab; 2006 Sep; 91(9):3382-8. PubMed ID: 16684835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesteryl ester transfer protein (CETP) -629C/A polymorphism and it's effects on the serum lipid levels in metabolic syndrome patients.
    Akbarzadeh M; Hassanzadeh T; Saidijam M; Esmaeili R; Borzouei Sh; Hajilooi M; Mahjub H; Paoli M
    Mol Biol Rep; 2012 Oct; 39(10):9529-34. PubMed ID: 22729881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP mice.
    de Haan W; van der Hoogt CC; Westerterp M; Hoekstra M; Dallinga-Thie GM; Princen HM; Romijn JA; Jukema JW; Havekes LM; Rensen PC
    Atherosclerosis; 2008 Mar; 197(1):57-63. PubMed ID: 17868678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.